New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Report Size Share Growth Drivers Trends Opportunities & Forecast 2025–2030

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market at USD 160 Mn, fueled by chronic diseases, biologics, and regulatory enhancements for safe injectable packaging.

Region:Global

Author(s):Rebecca

Product Code:KRAB2263

Pages:98

Published On:January 2026

About the Report

Base Year 2024

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Overview

  • The New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market is valued at USD 160 million, based on a five-year historical analysis, in line with the strong global expansion of prefilled syringes and related primary pharmaceutical packaging solutions. This growth is primarily driven by the increasing demand for biologics and biosimilars, as well as the rising prevalence of chronic diseases such as diabetes, rheumatoid arthritis, and cardiovascular diseases that frequently require injectable therapies. The market is also supported by advancements in packaging technologies, including ready-to-use containers, automated high-speed filling and inspection lines, and improved barrier glass and elastomer components that enhance product safety, sterility assurance, and drug stability.
  • Auckland and Wellington are the dominant cities in this market, primarily due to their robust healthcare infrastructure and concentration of pharmaceutical, biotechnology, and contract manufacturing organizations, which act as key demand centers for injectable drug packaging solutions. These cities are home to major public and private hospitals, research institutions, and life sciences clusters, facilitating innovation, collaboration, and adoption of advanced sterile packaging equipment, which further drives market growth.
  • In 2023, the New Zealand government strengthened requirements around the integrity and security of medicines packaging for prescription and hospital-use products, including injectables, through the enforcement of standards under the Medicines Act 1981 and the Medicines Regulations 1984, as administered by Medsafe, particularly referencing Good Manufacturing Practice (GMP) requirements for tamper-evident packaging and secure closure systems for finished medicinal products. These requirements aim to enhance patient safety and ensure the integrity of pharmaceutical products throughout the supply chain, thereby influencing the selection, design, and validation of packaging equipment used for glass prefilled syringes and glass vials.
New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Size

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Segmentation

By Equipment Type:The equipment type segmentation includes various machinery essential for the packaging process. The subsegments are Filling and Closing Machines, Washing and Sterilization Equipment, Inspection and Leak Detection Systems, Labeling and Serialization Equipment, Secondary and Tertiary Packaging Equipment, and Others. Among these, Filling and Closing Machines dominate the market due to their critical role in ensuring the accurate and safe filling of syringes and vials, which is essential for maintaining product integrity and compliance with aseptic processing and GMP standards, especially for high-value biologics and vaccines.

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market segmentation by Equipment Type.

By Packaging Format:The packaging format segmentation includes Glass Prefilled Syringe Packaging Lines, Glass Vial Packaging Lines, Combination and Flexible Packaging Lines, and Others. Glass Prefilled Syringe Packaging Lines are leading this segment due to the increasing preference for prefilled syringes among healthcare providers and patients, as they offer convenience, reduced risk of contamination, lower medication errors, and improved dosing accuracy, aligning with global trends favoring prefilled and ready-to-use delivery systems for chronic disease management and self-administration.

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market segmentation by Packaging Format.

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Competitive Landscape

The New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market is characterized by a dynamic mix of regional and international players. Leading participants such as Becton, Dickinson and Company (BD), Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Inc., Nipro Corporation, AptarGroup, Inc., Stevanato Group S.p.A (including Ompi), Syntegon Technology GmbH, IMA Group, Bausch+Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG, Romaco Group, Marchesini Group S.p.A., Optima packaging group GmbH, Tofflon Science and Technology Co., Ltd., MAQUINARIA INDUSTRIAL DAPSA and Other Emerging Local/Regional Players contribute to innovation, geographic expansion, and service delivery in this space.

Becton, Dickinson and Company (BD)

1897

Franklin Lakes, New Jersey, USA

Gerresheimer AG

1864

Düsseldorf, Germany

SCHOTT AG

1884

Mainz, Germany

West Pharmaceutical Services, Inc.

1923

Exton, Pennsylvania, USA

Nipro Corporation

1954

Osaka, Japan

Company

Establishment Year

Headquarters

Group Size (Large, Mid-cap, or Small/Emerging)

New Zealand Market Revenue (NZD, latest year)

3-Year Revenue CAGR in New Zealand (%)

Installed Base of Packaging Lines (Number of Lines in New Zealand)

Order Intake / Backlog (Value, NZD)

Market Share in Glass Prefilled Syringe & Vial Packaging Equipment (%)

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Industry Analysis

Growth Drivers

  • Increasing Demand for Biologics:The New Zealand biologics market is projected to reach NZD 1.5 billion in the future, driven by the rising prevalence of chronic diseases. This surge in biologics necessitates advanced packaging solutions, particularly glass prefilled syringes and vials, which ensure drug stability and safety. The World Health Organization reported that biologics accounted for 30% of total pharmaceutical sales in the future, highlighting the critical need for efficient packaging systems in this sector.
  • Advancements in Packaging Technology:The New Zealand packaging equipment sector is expected to grow by NZD 200 million in the future, fueled by innovations in automation and smart packaging technologies. These advancements enhance production efficiency and reduce human error, which is vital for maintaining the integrity of sensitive biologics. The integration of IoT in packaging processes is projected to increase operational efficiency by 25%, further driving demand for sophisticated packaging solutions in the healthcare industry.
  • Rising Healthcare Expenditure:New Zealand's healthcare expenditure is anticipated to reach NZD 22 billion in the future, reflecting a 5% increase from the previous period. This rise is primarily due to government initiatives aimed at improving healthcare access and quality. Increased funding for healthcare services directly correlates with the demand for advanced packaging solutions, as healthcare providers seek reliable and safe delivery methods for medications, particularly biologics that require stringent packaging standards.

Market Challenges

  • High Initial Investment Costs:The capital required for setting up glass vial and prefilled syringe manufacturing facilities in New Zealand can exceed NZD 10 million. This significant financial barrier can deter new entrants and limit the expansion of existing companies. Additionally, the high costs associated with acquiring advanced machinery and technology further complicate market entry, making it challenging for smaller firms to compete effectively in this specialized sector.
  • Stringent Regulatory Requirements:Compliance with Medsafe regulations and Good Manufacturing Practices (GMP) is mandatory for all packaging equipment manufacturers in New Zealand. The costs associated with meeting these stringent standards can reach NZD 1 million annually for mid-sized companies. These regulatory hurdles not only increase operational costs but also extend the time required for product development and market entry, posing a significant challenge for industry players.

New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Future Outlook

The future of the New Zealand glass prefilled syringes and vials packaging equipment market appears promising, driven by technological advancements and increasing healthcare investments. As the demand for biologics continues to rise, manufacturers are likely to focus on automation and smart packaging solutions to enhance efficiency. Additionally, sustainability trends will push companies to innovate eco-friendly packaging options, aligning with global environmental goals while meeting local regulatory standards, thus fostering growth in this sector.

Market Opportunities

  • Expansion into Emerging Markets:New Zealand manufacturers have the opportunity to expand their reach into emerging markets in the Asia-Pacific region, where healthcare spending is projected to grow by 7% annually. This expansion can lead to increased sales of glass prefilled syringes and vials, capitalizing on the rising demand for biologics in these markets.
  • Development of Eco-Friendly Packaging:The growing emphasis on sustainability presents a significant opportunity for manufacturers to innovate eco-friendly packaging solutions. By investing in biodegradable materials and recyclable designs, companies can not only meet regulatory requirements but also attract environmentally conscious consumers, potentially increasing market share in a competitive landscape.

Scope of the Report

SegmentSub-Segments
By Equipment Type

Filling and Closing Machines

Washing and Sterilization Equipment

Inspection and Leak Detection Systems

Labeling and Serialization Equipment

Secondary and Tertiary Packaging Equipment

Others

By Packaging Format

Glass Prefilled Syringe Packaging Lines

Glass Vial Packaging Lines

Combination and Flexible Packaging Lines

Others

By Automation Level

Fully Automated Systems

Semi-Automated Systems

Manual and Standalone Equipment

By Application

Vaccines and Immunization Products

Biologics and Biosimilars

Oncology and Specialty Injectables

Chronic Disease Therapies (e.g., diabetes, autoimmune)

Others

By End-User

Pharmaceutical Manufacturers

Biotechnology Companies

Contract Development and Manufacturing Organizations (CDMOs/CMOs)

Hospital and Compounding Pharmacies

Others

By Material Handling & Container Type

Borosilicate Glass Containers

Aluminosilicate and Other High-Performance Glass

Ready-to-Fill / Ready-to-Use (RTF/RTU) Glass Containers

Bulk Glass Containers

By Region

North Island

South Island

Others

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Medsafe, Ministry of Health)

Pharmaceutical Manufacturers

Biotechnology Companies

Medical Device Manufacturers

Packaging Equipment Suppliers

Logistics and Supply Chain Companies

Quality Assurance and Compliance Organizations

Players Mentioned in the Report:

Becton, Dickinson and Company (BD)

Gerresheimer AG

SCHOTT AG

West Pharmaceutical Services, Inc.

Nipro Corporation

AptarGroup, Inc.

Stevanato Group S.p.A (including Ompi)

Syntegon Technology GmbH

IMA Group

Bausch+Strobel Maschinenfabrik Ilshofen GmbH + Co. KG

Romaco Group

Marchesini Group S.p.A.

Optima packaging group GmbH

Tofflon Science and Technology Co., Ltd.

MAQUINARIA INDUSTRIAL DAPSA and Other Emerging Local/Regional Players

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Analysis

3.1 Growth Drivers

3.1.1 Increasing demand for biologics
3.1.2 Advancements in packaging technology
3.1.3 Rising healthcare expenditure
3.1.4 Growing focus on patient safety

3.2 Market Challenges

3.2.1 High initial investment costs
3.2.2 Stringent regulatory requirements
3.2.3 Competition from alternative packaging solutions
3.2.4 Supply chain disruptions

3.3 Market Opportunities

3.3.1 Expansion into emerging markets
3.3.2 Development of eco-friendly packaging
3.3.3 Strategic partnerships with pharmaceutical companies
3.3.4 Technological innovations in manufacturing

3.4 Market Trends

3.4.1 Shift towards automation in packaging
3.4.2 Increasing use of smart packaging solutions
3.4.3 Growing preference for prefilled syringes
3.4.4 Emphasis on sustainability in packaging

3.5 Government Regulation

3.5.1 Compliance with Medsafe regulations
3.5.2 Adherence to GMP standards
3.5.3 Environmental regulations on packaging waste
3.5.4 Safety standards for medical devices

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Segmentation

8.1 By Equipment Type

8.1.1 Filling and Closing Machines
8.1.2 Washing and Sterilization Equipment
8.1.3 Inspection and Leak Detection Systems
8.1.4 Labeling and Serialization Equipment
8.1.5 Secondary and Tertiary Packaging Equipment
8.1.6 Others

8.2 By Packaging Format

8.2.1 Glass Prefilled Syringe Packaging Lines
8.2.2 Glass Vial Packaging Lines
8.2.3 Combination and Flexible Packaging Lines
8.2.4 Others

8.3 By Automation Level

8.3.1 Fully Automated Systems
8.3.2 Semi-Automated Systems
8.3.3 Manual and Standalone Equipment

8.4 By Application

8.4.1 Vaccines and Immunization Products
8.4.2 Biologics and Biosimilars
8.4.3 Oncology and Specialty Injectables
8.4.4 Chronic Disease Therapies (e.g., diabetes, autoimmune)
8.4.5 Others

8.5 By End-User

8.5.1 Pharmaceutical Manufacturers
8.5.2 Biotechnology Companies
8.5.3 Contract Development and Manufacturing Organizations (CDMOs/CMOs)
8.5.4 Hospital and Compounding Pharmacies
8.5.5 Others

8.6 By Material Handling & Container Type

8.6.1 Borosilicate Glass Containers
8.6.2 Aluminosilicate and Other High-Performance Glass
8.6.3 Ready-to-Fill / Ready-to-Use (RTF/RTU) Glass Containers
8.6.4 Bulk Glass Containers

8.7 By Region

8.7.1 North Island
8.7.2 South Island
8.7.3 Others

9. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Mid-cap, or Small/Emerging)
9.2.3 New Zealand Market Revenue (NZD, latest year)
9.2.4 3-Year Revenue CAGR in New Zealand (%)
9.2.5 Installed Base of Packaging Lines (Number of Lines in New Zealand)
9.2.6 Order Intake / Backlog (Value, NZD)
9.2.7 Market Share in Glass Prefilled Syringe & Vial Packaging Equipment (%)
9.2.8 Average Deal Size (NZD per Project)
9.2.9 EBITDA Margin (%)
9.2.10 R&D Intensity (% of Revenue)
9.2.11 Capex Intensity (% of Revenue)
9.2.12 On-time Project Delivery Rate (%)
9.2.13 After-Sales / Service Revenue Share (%)
9.2.14 Customer Retention / Renewal Rate (%)
9.2.15 Net Promoter Score (NPS) / Customer Satisfaction Index

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Becton, Dickinson and Company (BD)
9.5.2 Gerresheimer AG
9.5.3 SCHOTT AG
9.5.4 West Pharmaceutical Services, Inc.
9.5.5 Nipro Corporation
9.5.6 AptarGroup, Inc.
9.5.7 Stevanato Group S.p.A (including Ompi)
9.5.8 Syntegon Technology GmbH
9.5.9 IMA Group
9.5.10 Bausch+Ströbel Maschinenfabrik Ilshofen GmbH + Co. KG
9.5.11 Romaco Group
9.5.12 Marchesini Group S.p.A.
9.5.13 Optima packaging group GmbH
9.5.14 Tofflon Science and Technology Co., Ltd.
9.5.15 MAQUINARIA INDUSTRIAL DAPSA and Other Emerging Local/Regional Players

10. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation Trends
10.1.2 Decision-Making Processes
10.1.3 Supplier Selection Criteria
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment Trends
10.2.2 Budget Prioritization
10.2.3 Cost Management Strategies
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Quality Assurance Issues
10.3.2 Supply Chain Challenges
10.3.3 Regulatory Compliance Difficulties
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Training and Support Needs
10.4.2 Technology Adoption Barriers
10.4.3 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Performance Metrics
10.5.2 User Feedback Mechanisms
10.5.3 Future Use Cases
10.5.4 Others

11. New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Framework


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-Ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-Sales Service


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-Term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Tracking
15.2.2 Activity Scheduling

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from New Zealand's Ministry of Health and relevant health authorities
  • Review of market studies and publications from packaging industry associations
  • Examination of trade statistics and import/export data specific to glass prefilled syringes and vials

Primary Research

  • Interviews with key stakeholders in pharmaceutical companies utilizing glass packaging
  • Surveys with packaging equipment manufacturers and suppliers in New Zealand
  • Field interviews with regulatory experts and quality assurance managers in the healthcare sector

Validation & Triangulation

  • Cross-validation of findings through multiple data sources including industry reports and expert opinions
  • Triangulation of market data with insights from trade associations and government publications
  • Sanity checks conducted through expert panel discussions to ensure data reliability

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of market size based on national healthcare expenditure and pharmaceutical sales data
  • Segmentation of the market by application areas such as vaccines, biologics, and other pharmaceuticals
  • Incorporation of growth trends in the biopharmaceutical sector influencing packaging needs

Bottom-up Modeling

  • Volume estimates derived from production capacities of leading glass vial and syringe manufacturers
  • Cost analysis based on pricing models of packaging equipment and materials
  • Calculation of market size based on projected sales volumes and average selling prices

Forecasting & Scenario Analysis

  • Multi-variable forecasting using historical growth rates and emerging market trends
  • Scenario analysis based on potential regulatory changes and technological advancements in packaging
  • Development of baseline, optimistic, and pessimistic market projections through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Pharmaceutical Manufacturers90Production Managers, Quality Control Officers
Healthcare Providers70Pharmacists, Hospital Procurement Officers
Packaging Equipment Suppliers55Sales Managers, Technical Support Engineers
Regulatory Bodies45Compliance Officers, Regulatory Affairs Specialists
Research Institutions40Research Scientists, Market Analysts

Frequently Asked Questions

What is the current value of the New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market?

The New Zealand Glass Prefilled Syringes Glass Vials Packaging Equipment Market is valued at approximately USD 160 million, reflecting significant growth driven by the increasing demand for biologics and the prevalence of chronic diseases requiring injectable therapies.

What factors are driving the growth of the glass prefilled syringes market in New Zealand?

Which cities in New Zealand are leading in the glass prefilled syringes market?

What are the regulatory requirements for packaging equipment in New Zealand?

Other Adjacent Reports

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022